2008 - Aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent stroke

Sloan, Michael A.
February 2009
ACP Journal Club;2/17/2009, Vol. 150 Issue 2, p6
Academic Journal
The article presents a research conducted by R.L. Sacco and colleagues to find whether aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent stroke. The study was conducted on 20,332 patients of 50 years of age, who had had an ischemic stroke in the previous 120 days and were clinically and neurologically stable.


Related Articles

  • News in brief...  // PharmacoEconomics & Outcomes News;6/5/2004, Issue 454, p6 

    Reports on a study on a level of aspirin underutilization among those who could benefit most from preventive aspirin therapy. Procedure for the study; Percentage of patients with coronary heart disease who were using aspirin.

  • Journal Watch.  // Pulse;3/23/2006, Vol. 66 Issue 12, p24 

    The article reports on the findings of several medical research. An international trial found that dual-therapy with aspirin and clopidogrel is not better than aspirin alone for preventing cardiovascular events in high-risk patients. A German research found that periodontal infections may...

  • Should you add aspirin to your heart patient's warfarin regimen?  // Journal of Family Practice;Jun2007, Vol. 56 Issue 6, p430 

    The article discusses the studies on the use of aspirin with warfarin regimens for cardiac patients. The study showed that aspirin does not reduce the risk of death or thromboembolism in patients with coronary artery disease. However, it showed that it brings benefits to patients with mechanical...

  • Analysis of the upper gastrointestinal tract bleeding prevalence in patients treated due ischaemic heart disease. Popławski, C.; Jakubczyk, P.; Jakubczyk, M. // Advances in Medical Sciences (De Gruyter Open);2007, Vol. 52, p288 

    Purpose: The analysis concerning the frequency of bleedings from the upper part of the gastrointestinal tract in group of patients suffering from ischaemic heart disease (IHD) treated and not treated with coronaroplasty. The other aim of the study was to analyse the incidence of using particular...

  • Aspirin adherence wanes in patients with depression.  // PharmacoEconomics & Outcomes News;3/26/2005, Issue 474, p6 

    Presents the results of a study on the adherence of patients with heart disease showing signs of depression, to prescribed aspirin therapy following an acute coronary syndrome. Use of the Medication Event Monitoring System in assessing the adherence of patients to aspirin; Comparison between...

  • 2008 - Telmisartan did not prevent recurrent stroke or major cardiovascular events. Michael A. Sloan, Michael A.X // ACP Journal Club;2/17/2009, Vol. 150 Issue 2, p7 

    The article presents a research conducted by researcher S. Yusuf and colleagues to find whether telmisartan in patients with ischemic stroke will prevent recurrent stroke. The study was conducted on 20,332 patients of 50 years of age, who had had an ischemic stroke in the previous 120 days and...

  • Disease progression and adverse events in patients listed for elective percutaneous coronary intervention. Taiwar, S.; Karpha, M.; Thomas, R.; Vurwerk, C.; Cox, I. C.; Burrell, C. J.; Motwani, J. G.; Gilbert, T. J.; Haywood, G. A. // Heart;Jan2006, Vol. 92 Issue 1, p112 

    This article focuses on a study whose objective was to record disease progression and the timing of adverse events in patients on a waiting list for elective percutaneous coronary intervention (PCI). Death, myocardial infarction, and need for urgent hospitalization because of unstable angina,...

  • Citalopram reduced depressive symptoms in coronary artery disease with depression: COMMENTARY. Linden, Wolfgang // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p68 

    The author comments on a study on the effectivity of citalopram and interpersonal psychotherapy in reducing depressive symptoms. He claimed that the study clarifies the existence of effective treatment options for depressed cardiac patients. It is asserted that there is no convincing evidence in...

  • Intraoperative PaO2 is not related to the development of surgical site infections after major cardiac surgery. Bustamante, Juan; Tamayo, Eduardo; Álvarez, Francisco Javier; García-Cuenca, Israel; Flórez, Santiago; Fierro, Inma; Gómez-Herreras, José Ignacio // Journal of Cardiothoracic Surgery;2011, Vol. 6 Issue 1, p1 

    Background: The perioperative use of high inspired oxygen fraction (FIO2) for preventing surgical site infections (SSIs) has demonstrated a reduction in their incidence in some types of surgery however there exist some discrepancies in this respect. The aim of this study was to analyze the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics